Retrospective Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Apr 16, 2024; 12(11): 1918-1928
Published online Apr 16, 2024. doi: 10.12998/wjcc.v12.i11.1918
Table 3 The characteristics of serological indicators were examined for the first time after treatment
Parameters
CQCQD
Control
P value
Number of patients1920
HCT0.38 ± 0.010.41 ± 0.010.04
CRP (mg/L)43.70 ± 11.0629.09 ± 6.130.25
ALT (U/L)35.11 ± 6.7843.70 ± 11.930.55
AST (U/L)31.78 ± 5.5334.80 ± 7.280.75
ALB36.39 ± 1.1139.33 ± 0.990.06
UA (μmmol/L)258.83 ± 33.34341.65 ± 30.150.07
CERA62.61 ± 3.1868.15 ± 3.260.23